Gf Fund Management Co. Ltd. Regeneron Pharmaceuticals, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 31,801 shares of REGN stock, worth $19 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
31,801
Previous 31,042
2.45%
Holding current value
$19 Million
Previous $22.1 Billion
8.79%
% of portfolio
0.47%
Previous 0.48%
Shares
2 transactions
Others Institutions Holding REGN
# of Institutions
1,487Shares Held
87MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$5.56 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.06 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.23 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.89 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$2.84 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $64.2B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...